PVLA
PALVELLA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$150.56
−2.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 170.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.00x
- Price / sales
- —
- Price / cash flow
- -59.41x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- —
- EV / EBITDA
- -38.38x
- EV / EBIT
- -33.24x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026